Geode Capital Management, LLC Aim Immuno Tech Inc. Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 531,334 shares of AIM stock, worth $4.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
531,334
Previous 464,016
14.51%
Holding current value
$4.89 Million
Previous $92,000
31.52%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AIM
# of Institutions
37Shares Held
4.83MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.44MShares$22.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$6.43 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny318KShares$2.93 Million0.0% of portfolio
-
State Street Corp Boston, MA173KShares$1.59 Million0.0% of portfolio
-
Verition Fund Management LLC Greenwich, CT162KShares$1.49 Million0.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $443M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...